BeOne Medicines Ltd. (ADR)
General ticker "ONC" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $27.7B (TTM average)
BeOne Medicines Ltd. (ADR) follows the US Stock Market performance with the rate: 46.8%.
Estimated limits based on current volatility of 1.6%: low 318.01$, high 328.32$
Factors to consider:
- Total employees count: 240 as of 2015
- Current price 15.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [133.94$, 277.00$]
- 2025-12-31 to 2026-12-31 estimated range: [113.52$, 241.04$]
Financial Metrics affecting the ONC estimates:
- Negative: with PPE of -29.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.74 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 56.28 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -0.48 <= -0.15
- Negative: negative Net income
Short-term ONC quotes
Long-term ONC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $2,458.78MM | $3,810.24MM |
| Operating Expenses | $3,666.51MM | $4,378.44MM |
| Operating Income | $-1,207.74MM | $-568.20MM |
| Non-Operating Income | $381.90MM | $35.20MM |
| R&D Expense | $1,778.59MM | $1,953.30MM |
| Income(Loss) | $-825.84MM | $-533.00MM |
| Taxes | $55.87MM | $111.78MM |
| Profit(Loss)* | $-881.71MM | $-644.79MM |
| Stockholders Equity | $3,537.33MM | $3,332.22MM |
| Inventory | $416.12MM | $494.99MM |
| Assets | $5,805.27MM | $5,920.91MM |
| Operating Cash Flow | $-1,157.45MM | $-140.63MM |
| Capital expenditure | $596.26MM | $529.14MM |
| Investing Cash Flow | $60.00MM | $-548.35MM |
| Financing Cash Flow | $416.48MM | $193.45MM |
| Earnings Per Share** | $-8.45 | $-6.12 |
| Ordinary share to ADR | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.